Metastatic triple-negative breast cancer appears to be the latest hard-to-treat cancer to yield to the juggernaut that is now anti-PD-L1 immunotherapy... More »
Metastatic triple-negative breast cancer appears to be the latest hard-to-treat cancer to yield to the juggernaut that is now anti-PD-L1 immunotherapy... More »
WASHINGTON – A promising early Alzheimer’s treatment, a new finding in the brains of migraineurs, and a practice-changing stroke treatment study a... More »
T cells are still the most accurate urinary biomarker for lupus nephritis, reported Katharina Kopetschke and her coauthors.
In a study of 123 lupus p... More »
Medicare Part D recipients with rheumatoid arthritis face an average of over $2,700 per year in out-of-pocket expenses for biologic disease-modifying ... More »
GENEVA – Circulating tumor DNA currently has one role to play in routine management of lung cancer patients: To check at the time of diagnosis for a... More »
The U.S. Preventive Services Task Force is continuing to recommend routine mammograms every 2 years for women starting at age 50, according to newly r... More »
The U.S. Preventive Services Task Force is continuing to recommend routine mammograms every 2 years for women starting at age 50, according to newly r... More »
Adult brain tumor survivors taking donepezil, a drug approved for the treatment of Alzheimer’s disease, showed significant improvements in the cogni... More »
At the risk of stating the obvious, our patients are becoming increasingly complex. Life is prolonged and comorbidities accumulate, creating dizzying ... More »